rs606231354

Variant summary

Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The NM_001189.4(NKX3-2):​c.104_110delCGCCCGG​(p.Ala35GlyfsTer87) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000724 in 1,381,158 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. A35A) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 7.2e-7 ( 0 hom. )

Consequence

NKX3-2
NM_001189.4 frameshift

Scores

Not classified

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:3

Conservation

PhyloP100: 1.08

Publications

0 publications found
Variant links:
Genes affected
NKX3-2 (HGNC:951): (NK3 homeobox 2) Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in cell differentiation; negative regulation of chondrocyte differentiation; and regulation of transcription by RNA polymerase II. Predicted to act upstream of or within several processes, including animal organ development; embryonic skeletal system development; and intestinal epithelial cell development. Predicted to be part of chromatin. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
NKX3-2 Gene-Disease associations (from GenCC):
  • spondylo-megaepiphyseal-metaphyseal dysplasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 18 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 4-13544304-CCCGGGCG-C is Pathogenic according to our data. Variant chr4-13544304-CCCGGGCG-C is described in ClinVar as Pathogenic. ClinVar VariationId is 7493.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NKX3-2NM_001189.4 linkc.104_110delCGCCCGG p.Ala35GlyfsTer87 frameshift_variant Exon 1 of 2 ENST00000382438.6 NP_001180.1 P78367
NKX3-2XM_047416049.1 linkc.104_110delCGCCCGG p.Ala35GlyfsTer87 frameshift_variant Exon 2 of 3 XP_047272005.1
NKX3-2XM_047416050.1 linkc.104_110delCGCCCGG p.Ala35GlyfsTer87 frameshift_variant Exon 2 of 3 XP_047272006.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NKX3-2ENST00000382438.6 linkc.104_110delCGCCCGG p.Ala35GlyfsTer87 frameshift_variant Exon 1 of 2 1 NM_001189.4 ENSP00000371875.5 P78367

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
7.24e-7
AC:
1
AN:
1381158
Hom.:
0
AF XY:
0.00000146
AC XY:
1
AN XY:
682684
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
29432
American (AMR)
AF:
0.00
AC:
0
AN:
33566
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24474
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
78708
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
38536
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4030
European-Non Finnish (NFE)
AF:
9.26e-7
AC:
1
AN:
1079816
Other (OTH)
AF:
0.00
AC:
0
AN:
57410
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000151

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Spondylo-megaepiphyseal-metaphyseal dysplasia Pathogenic:2
May 04, 2022
Mendelics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 01, 2009
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

not provided Pathogenic:1
Sep 18, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Ala35Glyfs*87) in the NKX3-2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NKX3-2 are known to be pathogenic (PMID: 20004766). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with spondylo-megaepiphyseal-metaphyseal dysplasia (PMID: 20004766). ClinVar contains an entry for this variant (Variation ID: 7493). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.1
Mutation Taster
=19/181
disease causing (ClinVar)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs606231354; hg19: chr4-13545928; API